LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $852,781 | +37.5% | 14,232 | +158.2% | 0.00% | 0.0% |
| Q1 2022 | $620,000 | -67.1% | 5,512 | -54.8% | 0.00% | -66.7% |
| Q4 2021 | $1,884,000 | +193.9% | 12,200 | +165.2% | 0.01% | +100.0% |
| Q3 2021 | $641,000 | -35.3% | 4,600 | -29.2% | 0.00% | -25.0% |
| Q1 2021 | $990,000 | +145.7% | 6,500 | +80.6% | 0.00% | +100.0% |
| Q2 2020 | $403,000 | -77.3% | 3,600 | -78.8% | 0.00% | -84.6% |
| Q4 2019 | $1,772,000 | +78.1% | 17,000 | +70.0% | 0.01% | +62.5% |
| Q3 2019 | $995,000 | -65.4% | 10,000 | -60.3% | 0.01% | -68.0% |
| Q2 2019 | $2,877,000 | +1244.4% | 25,200 | +1382.4% | 0.02% | +1150.0% |
| Q1 2019 | $214,000 | -14.4% | 1,700 | -7.8% | 0.00% | +100.0% |
| Q4 2018 | $250,000 | -92.6% | 1,844 | -85.0% | 0.00% | -94.4% |
| Q3 2018 | $3,376,000 | +41.7% | 12,300 | +7.0% | 0.02% | +38.5% |
| Q2 2018 | $2,383,000 | +11815.0% | 11,500 | +5650.0% | 0.01% | – |
| Q2 2015 | $20,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |